Trident Lifeline Ltd

Trident Lifeline Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Trident Lifeline Ltd

₹ 299 3.57%
23 Jan - close price
tridentlifeline.com BSE - SME: 543616
About

Incorporated in 2014, Trident Lifeline Ltd manufactures and sells pharmaceuticals
products[1]

Key Points

Business Overview:[1]
TFL is a pharmaceutical Company with business operations spanning formulations under its own brands, loan licence model and contract manufacturing model.
a) Pharmaceutical formulations export:
Company has a presence in 40 countries, including African, Latin America, and East
Asian countries, with ~945 registered export market products, and ~2016 export market products are under registration
b) Contract manufacturing:
Company follows an Asset-light third-party contract manufacturing model thus entailing limited direct investment in manufacturing capacities

Website BSE
  • Market Cap ₹ 356 Cr.
  • Current Price ₹ 299
  • High / Low ₹ 328 / 222
  • Stock P/E 18.4
  • Book Value ₹ 67.8
  • Dividend Yield 0.00 %
  • ROCE 18.1 %
  • ROE 20.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter
  • Promoter holding has increased by 1.01% over last quarter.
  • Company's working capital requirements have reduced from 208 days to 144 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Earnings include an other income of Rs.9.52 Cr.
  • Promoter holding has decreased over last 3 years: -5.74%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2022 Dec 2022 Mar 2023 Jun 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
5.97 9.41 8.46 8.64 7.09 19.13 13.15 15.45 11.83 34.01 23.61 31.34 25.71
5.11 7.43 6.52 6.88 5.66 16.77 10.66 11.40 7.76 25.47 18.44 24.48 20.62
Operating Profit 0.86 1.98 1.94 1.76 1.43 2.36 2.49 4.05 4.07 8.54 5.17 6.86 5.09
OPM % 14.41% 21.04% 22.93% 20.37% 20.17% 12.34% 18.94% 26.21% 34.40% 25.11% 21.90% 21.89% 19.80%
0.01 0.39 0.64 0.33 0.25 1.47 1.15 0.54 0.56 1.87 1.35 1.67 4.63
Interest 0.08 0.13 0.15 0.10 0.15 0.37 0.49 0.50 0.55 1.55 1.13 0.99 1.24
Depreciation 0.09 0.13 0.12 0.13 0.19 0.39 0.54 0.16 0.61 2.74 1.46 0.91 2.46
Profit before tax 0.70 2.11 2.31 1.86 1.34 3.07 2.61 3.93 3.47 6.12 3.93 6.63 6.02
Tax % 0.00% 4.74% 14.29% 24.73% 21.64% 46.91% 38.70% 28.50% 26.51% -0.33% 29.26% 23.23% 22.76%
0.70 2.02 1.98 1.40 1.05 1.63 1.60 2.80 2.56 6.14 2.78 5.09 4.64
EPS in Rs 0.88 1.76 1.72 1.22 0.94 1.77 1.99 2.69 2.43 6.15 2.66 4.27 3.60
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
22 32 45 87 115
19 25 36 72 89
Operating Profit 3 6 8 15 26
OPM % 12% 20% 18% 17% 22%
1 1 2 8 10
Interest 0 0 1 4 5
Depreciation 0 0 1 5 8
Profit before tax 3 7 9 14 23
Tax % -32% 8% 32% 23%
4 6 6 10 19
EPS in Rs 4.94 5.24 5.51 10.22 16.68
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 59%
TTM: 93%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 44%
TTM: 90%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 29%
1 Year: 11%
Return on Equity
10 Years: %
5 Years: %
3 Years: 18%
Last Year: 20%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 8 12 12 12 12
Reserves -3 34 41 53 69
2 8 18 54 59
7 9 16 37 47
Total Liabilities 14 63 87 156 187
1 3 21 44 46
CWIP 0 5 4 2 2
Investments 0 3 4 11 9
12 51 58 99 130
Total Assets 14 63 87 156 187

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0 -19 2 -10
-0 -10 -20 -14
1 42 11 20
Net Cash Flow 0 14 -7 -4

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 83 139 110 116
Inventory Days 95 129 156 226
Days Payable 134 87 94 119
Cash Conversion Cycle 44 182 173 224
Working Capital Days 49 275 205 144
ROCE % 23% 15% 18%

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
69.99% 70.04% 70.04% 70.04% 67.48% 65.50% 62.99% 62.99% 63.04% 63.04% 63.10% 64.11%
4.39% 4.36% 4.64% 4.64% 6.02% 6.02% 6.09% 6.09% 6.62% 7.21% 7.71% 7.04%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.09% 0.39% 0.41% 0.35%
25.61% 25.58% 25.31% 25.31% 26.49% 28.47% 30.93% 30.92% 30.25% 29.35% 28.77% 28.50%
No. of Shareholders 388387439481500502507523534549554575

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • Jan 2026
    Transcript
    AI Summary
    PPT
  • Nov 2025
    Transcript
    AI Summary
    PPT
  • Jul 2025
    Transcript
    AI Summary
    PPT
  • Oct 2024
    Transcript
    AI Summary
    PPT
  • Jul 2024
    Transcript
    AI Summary
    PPT
  • May 2024
    Transcript
    AI Summary
    PPT
  • Nov 2023
    Transcript
    AI Summary
    PPT
  • Jul 2023
    Transcript
    AI Summary
    PPT
  • May 2023
    Transcript
    AI Summary
    PPT
  • Jan 2023
    Transcript
    AI Summary
    PPT